23 May 2013
Keywords: bi, micardis, provides, sustained, bp, control, data
Article | 28 June 2004
Data presented at the 14th European Society of Hypertension held in Paris, France, show that Boehringer Ingelheim's Micardis (telmisartan)
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 June 2004
9 August 2004
31 May 2004
© 2013 thepharmaletter.com